While TMB has emerged as a biomarker with potential relevance to many tumor types, significant uncertainty remains regarding the overall utility of TMB testing. Building on the 2018 webinar series, “Tumor Mutational Burden: Challenges and Opportunities for Improving Cancer Patient Care”, this new two-part series will provide up-to-date information surrounding TMB testing in the laboratory and utility in clinic.
Join us for this free online learning experience aimed at breaking down barriers to testing and treatment in Non-Small Cell Lung Cancer (NSCLC). In this five-part series world-renowned experts will explore best practices in test ordering, sample collection, and test interpretation with the goal of improving patient care.
Learn from AMP experts in these in-person courses.
These are courses or thematically bundled packages to help you develop skills needed for success in molecular pathology and diagnostics. All programs include an AMP Certificate of Completion after successfully completing watching all the talks and passing the exam with a grade of 75% of more. Some are also available for CME or CMLE credit.